Why the study?
Do multimodal prehabilitation programs improve outcomes in patients undergoing gastrointestinal cancer surgery?
Do multimodal prehabilitation programs improve outcomes in patients undergoing gastrointestinal cancer surgery?
Current evidence is insufficient to support the routine integration of multimodal prehabilitation programs in gastrointestinal cancer surgery.
Current evidence does not support routine multimodal prehabilitation in GI cancer surgery; leaves open its benefit pending further high-quality trials.
Although small studies are supportive of multimodal interventions, there are insufficient data to make a conclusion about the integration of prehabilitation in GI cancer surgery as a bundle of care. Larger, prospective trials, utilizing uniform objective risk stratification and structured interventions, with predefined clinical and health economic end points, are required before definitive value can be assigned to prehabilitation programs.
No takes yet. Share an insight, caveat, or question.
Bolshinsky et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: